Ofatumumab versus teriflunomide in relapsing MS: adaptive design of two Phase 3 studies (ASCLEPIOS I and ASCLEPIOS II)
Stephen L. Hauser,Amit Bar-Or,Jeffrey Cohen,Giancarlo Comi,Jorge Correale,Patricia K. Coyle,Anne Cross,Jerome De Seze,Xavier Montalban,Krzysztof Selmaj,Wiendl Heinz, Algirdas Kakarieka,Goeril Karlsson,Dieter A. Haring,Erik Wallstrom,Ludwig Kappos NEUROLOGY（2017）
AI 理解论文
溯源树
样例
